Our findings revealed that the DAPK promoter methylation rate was significantly higher in GC than nonmalignant samples, which suggested that DAPK inactivation via promoter methylation plays an important in the tumorgenesis of GC. The gene discussed is DAPK1; the disease is gastric cancer.